Class II · ModerateRecall completed
Cardura XL (doxazosin) extended release tablets 8mg
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot#: 8147041; Exp. June 2024 Lot#: 8163765; Exp. March 2025
Where it was soldU.S. Nationwide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Impurities/Degradation Specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byMade in Singapore
| Distributed by / for | Roerig Division of Pfizer Inc, NY, NY 10017 |
| NDC | 0049-2080-10 |
Show the full FDA record
| Full product label | Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10 |
| Recalling firm | Viatris Inc |
| Distribution | U.S. Nationwide |
| Quantity | 3,694 bottles |
| Recall initiated | 2024-04-30 |
| Report date | 2024-07-24 |
| Recall completed | — |
| Recall number | D-0603-2024 |
| Classification | Class II |
| FDA status | Completed |
| Origin on file | Canonsburg PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.